42 stories found
BioNTech is ceasing its COVID-19 vaccine production and closing several German plants, leading to 1,860 job cuts due to significantly decreased demand for the vaccines.
UniCredit Bank has announced a record quarterly profit, with its net profit in Czechia and Slovakia also seeing a significant increase. This financial performance highlights strong investment income for the banking group.
BioNTech's stock price target has been increased following the successful release of T-Pam data, indicating positive developments for the biotechnology company.
Pfizer and BioNTech have halted a U.S. COVID-19 vaccine study, citing difficulties in recruitment and weak demand for the shots.
The German scientist speaks with 'La Vanguardia' about the potential of mRNA against cancer, her decision to leave BioNTech, and the value of diversity in laboratories.
With their Covid vaccines, Ugur Sahin and Özlem Türeci became world-famous overnight. Now the doctor couple prefers to research again instead of managing.
Uğur Şahin és Özlem Türeci új mRNS-startupot alapítanak.
BioNTech shares experienced a decline following news of its co-founders' plans to exit the company and a financial outlook that missed market forecasts.
BioNTech shares fell after its co-founders announced plans to exit and the company's financial outlook missed forecasts.
Ugur Sahin e Oezlem Tuereci terão até ao final deste ano uma nova empresa dedicada a fazer avançar os medicamentos da próxima geração com ARN-mensageiro.
Uğur Şahin and Özlem Türeci, the co-founders of BioNTech, are stepping down from the German pharmaceutical company to pursue a new venture in mRNA technology.
Moderna is facing a lawsuit alleging that its COVID-19 vaccine violates a patent linked to the Pfizer/BioNTech shot.
BioNTech has announced plans to close several sites in Germany and Singapore, a move that will impact approximately 1,860 employees.
Morgan Stanley has slightly raised its price target for BioNTech SE (BNTX) as it updates its biopharma coverage models.
A new antibody-drug conjugate, Trastuzumab Pamirtecan, developed by BioNTech and DualityBio, has demonstrated clinically meaningful efficacy in patients with HER2-expressing, recurrent endometrial cancer. The findings suggest a promising new treatment option for this patient group.
BMO Capital has reduced its price target for BioNTech SE (BNTX) from $143 to $128.
BioNTech founders Uğur Şahin and Özlem Türeci are embarking on a new venture, with their original investors and co-founders, Thomas and Andreas Strüngmann, expressing interest in investing again. This move follows their stepping back from BioNTech's leadership, highlighting their continued focus on scientific innovation and entrepreneurship.
Ugur Sahin and Özlem Türeci, the founders of BioNTech, are reportedly stepping back from the company's operational management, a move described as a potentially strategic decision by the research couple.
BioNTech's stock has fallen sharply after its founders announced their departure, leading investors to question whether to buy the dip.
BioNTech shares declined following news that its cofounders plan to exit the company and after its financial outlook missed forecasts, causing the shares to fall.
The Turkish co-founders of BioNTech are leaving the company to establish a new enterprise focused on next-generation mRNA technology. This move comes as BioNTech continues to record significant achievements.
BioNTech’s Founding Duo Will Leave to Start New mRNA Firm Bloomberg.com
BioNTech sues Moderna for patent infringement over COVID shots Reuters
BioNTech announced plans to close several locations and eliminate up to 1,860 jobs as part of a restructuring effort.
The city of Mainz, known for Biontech, is reportedly considering implementing a tourist accommodation tax as its 'golden times' are over, indicating financial difficulties.
German biotechnology company BioNTech plans to close its vaccine manufacturing plant in Singapore by 2027, affecting 85 employees.
The founding couple of Biontech is stepping down from operational roles, prompting the company to search for a new CEO, primarily in the United States. The largest shareholder defends the move, while Mainz hopes not to lose a valuable asset.
A BioNTech executive sold shares worth seven million dollars just one day after the company's founders announced their withdrawal from leadership, with the timing described as unfortunate despite the sale being pre-registered.
The co-founders of BioNTech have announced their departure from the company to establish a new venture focused on mRNA technology.
Dass sich Ugur Sahin und Özlem Türeci aus dem operativen Geschäft von Biontech zurückziehen, erscheint zunächst seltsam.
NATO has confirmed the deployment of a US Patriot air defense system in Turkey in response to two Iranian ballistic missiles detected by the Malatya radar station heading towards Turkish territory, reinforcing Turkey's air defenses.
BioNTech's shares declined following news that its cofounders plan to exit the company and after its financial outlook missed forecasts, causing the shares to fall.
These are the stocks posting the largest moves in early trading.
BioNTech SE (BNTX) is experiencing a rally in its stock due to a solid oncology strategy.